nodes	percent_of_prediction	percent_of_DWPC	metapath
Equilin—HSD17B1—The canonical retinoid cycle in rods (twilight vision)—TTR—Alzheimer's disease	0.155	0.222	CbGpPWpGaD
Equilin—HSD17B1—nervous system—Alzheimer's disease	0.0828	0.315	CbGeAlD
Equilin—HSD17B1—central nervous system—Alzheimer's disease	0.0798	0.303	CbGeAlD
Equilin—HSD17B1—brain—Alzheimer's disease	0.0633	0.241	CbGeAlD
Equilin—HSD17B1—Diseases associated with visual transduction—TTR—Alzheimer's disease	0.0482	0.0688	CbGpPWpGaD
Equilin—SHBG—Nongenotropic Androgen signaling—PLCB1—Alzheimer's disease	0.0328	0.0468	CbGpPWpGaD
Equilin—HSD17B1—Diseases associated with visual transduction—LRP1—Alzheimer's disease	0.0299	0.0427	CbGpPWpGaD
Equilin—SHBG—Nongenotropic Androgen signaling—CREB1—Alzheimer's disease	0.0179	0.0256	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	0.0166	0.0237	CbGpPWpGaD
Equilin—HSD17B1—Diseases associated with visual transduction—LPL—Alzheimer's disease	0.014	0.02	CbGpPWpGaD
Equilin—SHBG—central nervous system—Alzheimer's disease	0.0134	0.0511	CbGeAlD
Equilin—SHBG—cerebellum—Alzheimer's disease	0.0131	0.0499	CbGeAlD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	0.012	0.0171	CbGpPWpGaD
Equilin—HSD17B1—Diseases associated with visual transduction—CALM1—Alzheimer's disease	0.0118	0.0168	CbGpPWpGaD
Equilin—HSD17B1—Diseases associated with visual transduction—APOE—Alzheimer's disease	0.0117	0.0167	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	0.0111	0.0158	CbGpPWpGaD
Equilin—SHBG—brain—Alzheimer's disease	0.0107	0.0406	CbGeAlD
Equilin—Estriol—ESR1—Alzheimer's disease	0.00993	0.276	CrCbGaD
Equilin—HSD17B1—Disease—ITM2B—Alzheimer's disease	0.00883	0.0126	CbGpPWpGaD
Equilin—Estropipate—ESR1—Alzheimer's disease	0.00759	0.211	CrCbGaD
Equilin—HSD17B1—Metabolism—DHCR24—Alzheimer's disease	0.0074	0.0106	CbGpPWpGaD
Equilin—SHBG—Nongenotropic Androgen signaling—AKT1—Alzheimer's disease	0.00719	0.0103	CbGpPWpGaD
Equilin—HSD17B1—Disease—GAPDHS—Alzheimer's disease	0.00706	0.0101	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	0.0069	0.00984	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CA4—Alzheimer's disease	0.00629	0.00898	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	0.00615	0.00877	CbGpPWpGaD
Equilin—HSD17B1—Disease—TTR—Alzheimer's disease	0.00612	0.00874	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GAPDHS—Alzheimer's disease	0.00591	0.00844	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ATP5A1—Alzheimer's disease	0.00561	0.008	CbGpPWpGaD
Equilin—Ethinyl Estradiol—ESR1—Alzheimer's disease	0.00542	0.151	CrCbGaD
Equilin—HSD17B1—Metabolism—PLD3—Alzheimer's disease	0.00535	0.00763	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	0.00535	0.00763	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	0.00529	0.00754	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—HSD17B10—Alzheimer's disease	0.00513	0.00732	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	0.00501	0.00715	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP46A1—Alzheimer's disease	0.00494	0.00704	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ND1—Alzheimer's disease	0.00477	0.0068	CbGpPWpGaD
Equilin—Conjugated Estrogens—ESR1—Alzheimer's disease	0.00474	0.132	CrCbGaD
Equilin—Estrone—ESR1—Alzheimer's disease	0.00472	0.131	CrCbGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	0.00466	0.00665	CbGpPWpGaD
Equilin—HSD17B1—Disease—SNCA—Alzheimer's disease	0.00455	0.00649	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TTR—Alzheimer's disease	0.00429	0.00612	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	0.00426	0.00608	CbGpPWpGaD
Equilin—HSD17B1—Disease—PSENEN—Alzheimer's disease	0.00406	0.00579	CbGpPWpGaD
Equilin—HSD17B1—Disease—APH1A—Alzheimer's disease	0.004	0.00571	CbGpPWpGaD
Equilin—HSD17B1—Disease—NCSTN—Alzheimer's disease	0.00389	0.00556	CbGpPWpGaD
Equilin—HSD17B1—Disease—LRP1—Alzheimer's disease	0.0038	0.00542	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PYY—Alzheimer's disease	0.00375	0.00535	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	0.00367	0.00524	CbGpPWpGaD
Equilin—HSD17B1—Disease—TPI1—Alzheimer's disease	0.00367	0.00523	CbGpPWpGaD
Equilin—Estradiol—ESR1—Alzheimer's disease	0.00358	0.0995	CrCbGaD
Equilin—HSD17B1—Disease—EIF2AK2—Alzheimer's disease	0.00345	0.00492	CbGpPWpGaD
Equilin—HSD17B1—Disease—GAPDH—Alzheimer's disease	0.00339	0.00483	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	0.00334	0.00477	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CDK5—Alzheimer's disease	0.00325	0.00464	CbGpPWpGaD
Equilin—HSD17B1—Disease—PSEN2—Alzheimer's disease	0.00317	0.00452	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HTR6—Alzheimer's disease	0.00313	0.00446	CbGpPWpGaD
Equilin—HSD17B1—Disease—CST3—Alzheimer's disease	0.0031	0.00442	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—TPI1—Alzheimer's disease	0.00307	0.00438	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CHAT—Alzheimer's disease	0.00307	0.00438	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—MAOB—Alzheimer's disease	0.00295	0.0042	CbGpPWpGaD
Equilin—HSD17B1—Disease—IAPP—Alzheimer's disease	0.0029	0.00413	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PSENEN—Alzheimer's disease	0.00284	0.00405	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GAPDH—Alzheimer's disease	0.00284	0.00405	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	0.0028	0.004	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—APH1A—Alzheimer's disease	0.0028	0.004	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	0.00278	0.00396	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—A2M—Alzheimer's disease	0.00274	0.00391	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NCSTN—Alzheimer's disease	0.00273	0.00389	CbGpPWpGaD
Equilin—HSD17B1—Disease—ENO1—Alzheimer's disease	0.00267	0.0038	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—LRP1—Alzheimer's disease	0.00266	0.0038	CbGpPWpGaD
Equilin—HSD17B1—Disease—PPP3CA—Alzheimer's disease	0.00265	0.00378	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GAL—Alzheimer's disease	0.0026	0.00371	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GFAP—Alzheimer's disease	0.0026	0.00371	CbGpPWpGaD
Equilin—HSD17B1—Disease—GAB2—Alzheimer's disease	0.00254	0.00363	CbGpPWpGaD
Equilin—HSD17B1—Disease—GSK3A—Alzheimer's disease	0.00252	0.0036	CbGpPWpGaD
Equilin—HSD17B1—Disease—APP—Alzheimer's disease	0.00248	0.00354	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	0.00244	0.00348	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ACHE—Alzheimer's disease	0.00238	0.0034	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—INPP5D—Alzheimer's disease	0.00235	0.00336	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—A2M—Alzheimer's disease	0.00229	0.00327	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PTGS1—Alzheimer's disease	0.00223	0.00319	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ENO1—Alzheimer's disease	0.00223	0.00319	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PSEN2—Alzheimer's disease	0.00222	0.00316	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP2D6—Alzheimer's disease	0.00219	0.00312	CbGpPWpGaD
Equilin—HSD17B1—Disease—ADAM10—Alzheimer's disease	0.00213	0.00304	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—BCHE—Alzheimer's disease	0.00208	0.00296	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NPY—Alzheimer's disease	0.00204	0.00291	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IAPP—Alzheimer's disease	0.00203	0.00289	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CRH—Alzheimer's disease	0.00197	0.00281	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PLCB1—Alzheimer's disease	0.00196	0.00279	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	0.00192	0.00274	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ABCA1—Alzheimer's disease	0.0019	0.00271	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NPS—Alzheimer's disease	0.00187	0.00266	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PPP3CA—Alzheimer's disease	0.00186	0.00265	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PTK2B—Alzheimer's disease	0.00183	0.00261	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NTRK2—Alzheimer's disease	0.00178	0.00254	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GAB2—Alzheimer's disease	0.00178	0.00254	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SST—Alzheimer's disease	0.00178	0.00254	CbGpPWpGaD
Equilin—HSD17B1—Disease—LPL—Alzheimer's disease	0.00178	0.00254	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GSK3A—Alzheimer's disease	0.00176	0.00252	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—APP—Alzheimer's disease	0.00174	0.00248	CbGpPWpGaD
Equilin—HSD17B1—Disease—PRKCG—Alzheimer's disease	0.00173	0.00247	CbGpPWpGaD
Equilin—HSD17B1—Disease—CCR5—Alzheimer's disease	0.00164	0.00234	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PLCB1—Alzheimer's disease	0.00164	0.00234	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PPARGC1A—Alzheimer's disease	0.00164	0.00233	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—HMOX1—Alzheimer's disease	0.00163	0.00232	CbGpPWpGaD
Equilin—HSD17B1—Disease—MTHFR—Alzheimer's disease	0.0016	0.00228	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NGFR—Alzheimer's disease	0.00153	0.00218	CbGpPWpGaD
Equilin—HSD17B1—Disease—CALM1—Alzheimer's disease	0.0015	0.00213	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ADAM10—Alzheimer's disease	0.00149	0.00213	CbGpPWpGaD
Equilin—HSD17B1—Disease—APOE—Alzheimer's disease	0.00149	0.00213	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—LPL—Alzheimer's disease	0.00149	0.00213	CbGpPWpGaD
Equilin—HSD17B1—Disease—CAV1—Alzheimer's disease	0.00148	0.00211	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—S100B—Alzheimer's disease	0.00141	0.00201	CbGpPWpGaD
Equilin—HSD17B1—Disease—NOS2—Alzheimer's disease	0.00139	0.00198	CbGpPWpGaD
Equilin—HSD17B1—Disease—NOTCH1—Alzheimer's disease	0.00138	0.00196	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IGF2—Alzheimer's disease	0.00134	0.00192	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—MTHFR—Alzheimer's disease	0.00134	0.00191	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IGF1R—Alzheimer's disease	0.0013	0.00185	CbGpPWpGaD
Equilin—HSD17B1—Disease—GSK3B—Alzheimer's disease	0.00129	0.00184	CbGpPWpGaD
Equilin—HSD17B1—Disease—CREB1—Alzheimer's disease	0.00128	0.00183	CbGpPWpGaD
Equilin—HSD17B1—Disease—INS—Alzheimer's disease	0.00127	0.00182	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CALM1—Alzheimer's disease	0.00125	0.00179	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—APOE—Alzheimer's disease	0.00125	0.00178	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—LPL—Alzheimer's disease	0.00125	0.00178	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CAV1—Alzheimer's disease	0.00124	0.00176	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MEF2C—Alzheimer's disease	0.00123	0.00176	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PRKCG—Alzheimer's disease	0.00121	0.00173	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NGF—Alzheimer's disease	0.00118	0.00168	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CCR5—Alzheimer's disease	0.00115	0.00164	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HTR2A—Alzheimer's disease	0.00112	0.0016	CbGpPWpGaD
Equilin—HSD17B1—Disease—NOS3—Alzheimer's disease	0.00112	0.00159	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PPARG—Alzheimer's disease	0.00109	0.00155	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—INS—Alzheimer's disease	0.00107	0.00152	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CALM1—Alzheimer's disease	0.00105	0.00149	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—LEP—Alzheimer's disease	0.00104	0.00149	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—APOE—Alzheimer's disease	0.00104	0.00149	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CAV1—Alzheimer's disease	0.00103	0.00148	CbGpPWpGaD
Equilin—HSD17B1—Disease—PTGS2—Alzheimer's disease	0.00102	0.00146	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ESR1—Alzheimer's disease	0.000997	0.00142	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—F2—Alzheimer's disease	0.000984	0.0014	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NOTCH1—Alzheimer's disease	0.000963	0.00137	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—NOS3—Alzheimer's disease	0.000935	0.00133	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GSK3B—Alzheimer's disease	0.000904	0.00129	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CREB1—Alzheimer's disease	0.000897	0.00128	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—INS—Alzheimer's disease	0.000892	0.00127	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CCL2—Alzheimer's disease	0.000877	0.00125	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IGF1—Alzheimer's disease	0.000863	0.00123	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PTGS2—Alzheimer's disease	0.000855	0.00122	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NOS3—Alzheimer's disease	0.000782	0.00112	CbGpPWpGaD
Equilin—HSD17B1—Disease—TGFB1—Alzheimer's disease	0.000738	0.00105	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CASP3—Alzheimer's disease	0.000664	0.000947	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MAPK8—Alzheimer's disease	0.00061	0.000871	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—VEGFA—Alzheimer's disease	0.000563	0.000804	CbGpPWpGaD
Equilin—HSD17B1—Disease—IL6—Alzheimer's disease	0.000556	0.000794	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TGFB1—Alzheimer's disease	0.000517	0.000738	CbGpPWpGaD
Equilin—HSD17B1—Disease—AKT1—Alzheimer's disease	0.000513	0.000732	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—AKT1—Alzheimer's disease	0.00043	0.000613	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TP53—Alzheimer's disease	0.000426	0.000607	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IL6—Alzheimer's disease	0.00039	0.000556	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—AKT1—Alzheimer's disease	0.000359	0.000513	CbGpPWpGaD
